Skip to main content
Top
Published in: Applied Health Economics and Health Policy 4/2015

01-08-2015 | Original Research Article

A Comparison of Japan and UK SF-6D Health-State Valuations Using a Non-Parametric Bayesian Method

Author: Samer A. Kharroubi

Published in: Applied Health Economics and Health Policy | Issue 4/2015

Login to get access

Abstract

Background

There is interest in the extent to which valuations of health may differ between different countries and cultures, but few studies have compared preference values of health states obtained in different countries.

Objective

We sought to estimate and compare two directly elicited valuations for SF-6D health states between the Japan and UK general adult populations using Bayesian methods.

Methods

We analysed data from two SF-6D valuation studies where, using similar standard gamble protocols, values for 241 and 249 states were elicited from representative samples of the Japan and UK general adult populations, respectively. We estimate a function applicable across both countries that explicitly accounts for the differences between them, and is estimated using data from both countries.

Results

The results suggest that differences in SF-6D health-state valuations between the Japan and UK general populations are potentially important. The magnitude of these country-specific differences in health-state valuation depended, however, in a complex way on the levels of individual dimensions.

Conclusion

The new Bayesian non-parametric method is a powerful approach for analysing data from multiple nationalities or ethnic groups, to understand the differences between them and potentially to estimate the underlying utility functions more efficiently.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brazier JE, Ratcliffe J, Tsuchiya A, Solomon J. Measuring and valuing health for economic evaluation. Oxford: Oxford University Press; 2007. Brazier JE, Ratcliffe J, Tsuchiya A, Solomon J. Measuring and valuing health for economic evaluation. Oxford: Oxford University Press; 2007.
3.
go back to reference Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang Y, Wang QA. Multi-attribute utility function for a comprehensive health status classification system: Health Utilities Index Mark 2. Med Care. 1996;34(7):702–22.PubMedCrossRef Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang Y, Wang QA. Multi-attribute utility function for a comprehensive health status classification system: Health Utilities Index Mark 2. Med Care. 1996;34(7):702–22.PubMedCrossRef
4.
go back to reference Feeny DH, Furlong WJ, Torrance GW, Goldsmith CH, Zenglong Z, Depauw S, Denton M, Boyle M. Multi-attribute and single-attribute utility function for the Health Utility Index Mark 3 system. Med Care. 2002;40(20):113–28.PubMedCrossRef Feeny DH, Furlong WJ, Torrance GW, Goldsmith CH, Zenglong Z, Depauw S, Denton M, Boyle M. Multi-attribute and single-attribute utility function for the Health Utility Index Mark 3 system. Med Care. 2002;40(20):113–28.PubMedCrossRef
5.
go back to reference Hawthorne G, Richardson G, Atherton Day N. A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Ann Med. 2001;33:358–70.PubMedCrossRef Hawthorne G, Richardson G, Atherton Day N. A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Ann Med. 2001;33:358–70.PubMedCrossRef
6.
go back to reference Brazier JE, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271–92.PubMedCrossRef Brazier JE, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271–92.PubMedCrossRef
7.
go back to reference Revicki DA, Leidy NK, Brennan-Diemer F, Sorenson S, Togias A. Integrating patients’ preferences into health outcomes assessment: the multiattribute asthma symptom utility index. Chest. 1998;114(4):998–1007.PubMedCrossRef Revicki DA, Leidy NK, Brennan-Diemer F, Sorenson S, Togias A. Integrating patients’ preferences into health outcomes assessment: the multiattribute asthma symptom utility index. Chest. 1998;114(4):998–1007.PubMedCrossRef
8.
go back to reference Brazier JE, Czoski-Murray C, Roberts J, Brown M, Symonds T, Kelleher C. Estimation of a preference-based index from a condition specific measure: the King’s Health Questionnaire. Med Decis Making. 2008;28(1):113–26.PubMedCrossRef Brazier JE, Czoski-Murray C, Roberts J, Brown M, Symonds T, Kelleher C. Estimation of a preference-based index from a condition specific measure: the King’s Health Questionnaire. Med Decis Making. 2008;28(1):113–26.PubMedCrossRef
9.
go back to reference Yang Y, Brazier JE, Tsuchiya A, Coyne K. Estimating a preference-based index from the Overactive Bladder Questionnaire. Value Health. 2009;12:159–66.PubMedCrossRef Yang Y, Brazier JE, Tsuchiya A, Coyne K. Estimating a preference-based index from the Overactive Bladder Questionnaire. Value Health. 2009;12:159–66.PubMedCrossRef
10.
go back to reference Yang Y, Brazier JE, Tsuchiya A, Young T. Estimating a preference-based index for a 5-dimensional health state classification for asthma derived from the Asthma Quality of Life Questionnaire. Med Decis Making. 2011;31:281–91.PubMedCrossRef Yang Y, Brazier JE, Tsuchiya A, Young T. Estimating a preference-based index for a 5-dimensional health state classification for asthma derived from the Asthma Quality of Life Questionnaire. Med Decis Making. 2011;31:281–91.PubMedCrossRef
11.
go back to reference Drummond MF, Sculpher M, O’Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford Medical Publications; 2005. Drummond MF, Sculpher M, O’Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford Medical Publications; 2005.
12.
go back to reference Cruz LC, Camey SA, Hoffman JF, Rowen D, Brazier JE, Fleck MP, Polanczyk CA. Estimating the SF-6D value set for a Southern Brazilian Population. Value Health. 2011;14(5):S108–14.PubMedCrossRef Cruz LC, Camey SA, Hoffman JF, Rowen D, Brazier JE, Fleck MP, Polanczyk CA. Estimating the SF-6D value set for a Southern Brazilian Population. Value Health. 2011;14(5):S108–14.PubMedCrossRef
13.
go back to reference Ferreira LN, Ferreira PL, Brazier J, Rowen D. A Portugese value set for the SF-6D. Value Health. 2010;13(5):624–30.PubMedCrossRef Ferreira LN, Ferreira PL, Brazier J, Rowen D. A Portugese value set for the SF-6D. Value Health. 2010;13(5):624–30.PubMedCrossRef
14.
go back to reference Brazier JE, Fukuhara S, Roberts J, Kharoubi S, et al. Estimating a preference-based index from the Japanese SF-36. J Clin Epidemiol. 2009;62(12):1323–31.PubMedCrossRef Brazier JE, Fukuhara S, Roberts J, Kharoubi S, et al. Estimating a preference-based index from the Japanese SF-36. J Clin Epidemiol. 2009;62(12):1323–31.PubMedCrossRef
15.
go back to reference McGhee SM, Brazier J, Lam CLK, Wong LC, Chau J, Cheung A, Ho A. Quality adjusted life years: population specific measurement of the quality component. Hong Kong Med J. 2011;17(Suppl 6):S17–21. McGhee SM, Brazier J, Lam CLK, Wong LC, Chau J, Cheung A, Ho A. Quality adjusted life years: population specific measurement of the quality component. Hong Kong Med J. 2011;17(Suppl 6):S17–21.
16.
go back to reference Norman R, Viney R, Brazier J, Burgess L, Cronin P, King M, et al. Valuing SF-6D health states using a discrete choice experiment. Med Decis Making. 2013;34(6):773–86.PubMedCrossRef Norman R, Viney R, Brazier J, Burgess L, Cronin P, King M, et al. Valuing SF-6D health states using a discrete choice experiment. Med Decis Making. 2013;34(6):773–86.PubMedCrossRef
17.
go back to reference Johnson JA, Luo N, Shaw JW, Kind P, Coons SJ. Valuations of EQ-5D health states; are the United States and United Kingdom different. Med Care. 2005;43:221–8.PubMedCrossRef Johnson JA, Luo N, Shaw JW, Kind P, Coons SJ. Valuations of EQ-5D health states; are the United States and United Kingdom different. Med Care. 2005;43:221–8.PubMedCrossRef
18.
go back to reference Badia X, Roset M, Herdman M, Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making. 2001;20:7–16.CrossRef Badia X, Roset M, Herdman M, Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making. 2001;20:7–16.CrossRef
19.
go back to reference Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai S, Fukuda T, Hamashima C, Hisashige A, Tamura M. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11:341–53.PubMedCrossRef Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai S, Fukuda T, Hamashima C, Hisashige A, Tamura M. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11:341–53.PubMedCrossRef
20.
go back to reference Ferreira LN, Ferreira PL, Rowen D, Brazier J. Do Portuguese and UK health state values differ across valuation methods? Qual Life Res. 2011;20(4):609–19.PubMedCrossRef Ferreira LN, Ferreira PL, Rowen D, Brazier J. Do Portuguese and UK health state values differ across valuation methods? Qual Life Res. 2011;20(4):609–19.PubMedCrossRef
21.
go back to reference Kharroubi SA, O’Hagan A, Brazier JE. A comparison of United States and United Kingdom EQ-5D health state valuations using a nonparametric Bayesian method. Stat Med. 2010;29:1622–34.PubMed Kharroubi SA, O’Hagan A, Brazier JE. A comparison of United States and United Kingdom EQ-5D health state valuations using a nonparametric Bayesian method. Stat Med. 2010;29:1622–34.PubMed
22.
go back to reference Kharroubi SA, Brazier JE, McGhee S. A comparison of Hong Kong and United Kingdom SF-5D health state valuations using a nonparametric Bayesian method. Value Health. 2014;17(4):397–405.PubMedCrossRef Kharroubi SA, Brazier JE, McGhee S. A comparison of Hong Kong and United Kingdom SF-5D health state valuations using a nonparametric Bayesian method. Value Health. 2014;17(4):397–405.PubMedCrossRef
23.
go back to reference Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): conceptual framework and item selection. Med Care. 1992;30:473–83.PubMedCrossRef Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): conceptual framework and item selection. Med Care. 1992;30:473–83.PubMedCrossRef
24.
go back to reference Furlong W, Feeny D, Torrance GW, Barr R, Horsman J. Guide to design and development of health state utility instrumentation. Centre for Health Economics and Policy Analysis Paper 90-9, McMaster University, Hamilton, ON, 1990. Furlong W, Feeny D, Torrance GW, Barr R, Horsman J. Guide to design and development of health state utility instrumentation. Centre for Health Economics and Policy Analysis Paper 90-9, McMaster University, Hamilton, ON, 1990.
25.
go back to reference Patrick DL, Starks HE, Cain KC, Uhlmann RF, Pearlman RA. Measuring preferences for health states worse than death. Med Decis Making. 1994;14:9–18.PubMedCrossRef Patrick DL, Starks HE, Cain KC, Uhlmann RF, Pearlman RA. Measuring preferences for health states worse than death. Med Decis Making. 1994;14:9–18.PubMedCrossRef
26.
go back to reference Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol. 1997;51:1037–44.CrossRef Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol. 1997;51:1037–44.CrossRef
27.
go back to reference Fukuhara S, Ware JE, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol. 1998;51:1045–53.PubMedCrossRef Fukuhara S, Ware JE, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol. 1998;51:1045–53.PubMedCrossRef
28.
go back to reference Kharroubi SA, O’Hagan A, Brazier JE. Estimating utilities from individual health state preference data: a nonparametric Bayesian approach. Appl Stat. 2005;54:879–95. Kharroubi SA, O’Hagan A, Brazier JE. Estimating utilities from individual health state preference data: a nonparametric Bayesian approach. Appl Stat. 2005;54:879–95.
29.
go back to reference Kharroubi SA, O’Hagan A, Brazier JE. Modelling covariates for the SF-6D Standard Gamble health state preference data using a nonparametric Bayesian method. Soc Sci Med. 2007;64:1242–52.PubMedCrossRef Kharroubi SA, O’Hagan A, Brazier JE. Modelling covariates for the SF-6D Standard Gamble health state preference data using a nonparametric Bayesian method. Soc Sci Med. 2007;64:1242–52.PubMedCrossRef
30.
go back to reference Kharroubi SA, McCabe C. Modelling HUI 2 health state preference data using a nonparametric Bayesian method. Med Decis Making. 2008;28:875–87.PubMedCrossRef Kharroubi SA, McCabe C. Modelling HUI 2 health state preference data using a nonparametric Bayesian method. Med Decis Making. 2008;28:875–87.PubMedCrossRef
31.
go back to reference Lam CL, Brazier J, McGhee SM. Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value Health. 2008;11:295–303.PubMedCrossRef Lam CL, Brazier J, McGhee SM. Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value Health. 2008;11:295–303.PubMedCrossRef
Metadata
Title
A Comparison of Japan and UK SF-6D Health-State Valuations Using a Non-Parametric Bayesian Method
Author
Samer A. Kharroubi
Publication date
01-08-2015
Publisher
Springer International Publishing
Published in
Applied Health Economics and Health Policy / Issue 4/2015
Print ISSN: 1175-5652
Electronic ISSN: 1179-1896
DOI
https://doi.org/10.1007/s40258-015-0171-8

Other articles of this Issue 4/2015

Applied Health Economics and Health Policy 4/2015 Go to the issue